Healthcare provider profile · identity verified

Cheryl Ann Collins, ARNP - BC

Nurse Practitioner · LIVE OAK, FL · NPI 1477056976

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	302	110
Amlodipine Besylate	Amlodipine Besylate	209	76
Atorvastatin Calcium	Atorvastatin Calcium	207	81
Lisinopril	Lisinopril	187	68
Alprazolam	Alprazolam	158	28
Losartan Potassium	Losartan Potassium	151	50
Omeprazole	Omeprazole	139	53
Gabapentin	Gabapentin	132	51
Hydrochlorothiazide	Hydrochlorothiazide	127	51
Tramadol Hcl	Tramadol Hcl	125	35
Metformin Hcl	Metformin Hcl	121	39
Lorazepam	Lorazepam	108	18
Furosemide	Furosemide	103	40
Albuterol Sulfate Hfa	Albuterol Sulfate	99	45
Metoprolol Succinate	Metoprolol Succinate	96	35
Rosuvastatin Calcium	Rosuvastatin Calcium	92	30
Metoprolol Tartrate	Metoprolol Tartrate	91	28
Montelukast Sodium	Montelukast Sodium	88	32
Pantoprazole Sodium	Pantoprazole Sodium	88	35
Escitalopram Oxalate	Escitalopram Oxalate	85	26
Pregabalin	Pregabalin	80	12
Simvastatin	Simvastatin	71	24
Allopurinol	Allopurinol	70	20
Citalopram Hbr	Citalopram Hydrobromide	63	21
Ezetimibe	Ezetimibe	63	26
Fluticasone Propionate	Fluticasone Propionate	63	38
Clonazepam	Clonazepam	60	11
Trazodone Hcl	Trazodone Hcl	60	19
Methylprednisolone	Methylprednisolone	59	47
Potassium Chloride	Potassium Chloride	58	22
Eliquis	Apixaban	53	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	45
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	13
Tamsulosin Hcl	Tamsulosin Hcl	45	17
Glipizide	Glipizide	43	15
Metformin Hcl Er	Metformin Hcl	42	13
Hydralazine Hcl	Hydralazine Hcl	41	15
Atenolol	Atenolol	39	15
Clopidogrel	Clopidogrel Bisulfate	39	17
Famotidine	Famotidine	39	16
Jardiance	Empagliflozin	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	13
Doxycycline Monohydrate	Doxycycline Monohydrate	37	32
Sertraline Hcl	Sertraline Hcl	37	15
Buspirone Hcl	Buspirone Hcl	36	12
Carvedilol	Carvedilol	36	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Pravastatin Sodium	Pravastatin Sodium	34	15
Meloxicam	Meloxicam	32	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	16
Cephalexin	Cephalexin	27	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	22
Solifenacin Succinate	Solifenacin Succinate	27	14
Levetiracetam	Levetiracetam	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Trulicity	Dulaglutide	25	suppressed
Fluconazole	Fluconazole	24	suppressed
Ramipril	Ramipril	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Azithromycin	Azithromycin	23	23
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Finasteride	Finasteride	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Nitroglycerin	Nitroglycerin	21	15
Warfarin Sodium	Warfarin Sodium	21	suppressed
Ozempic	Semaglutide	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	11
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	16	13
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Temazepam	Temazepam	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Nystatin	Nystatin	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Letrozole	Letrozole	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Prednisone	Prednisone	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Topiramate	Topiramate	12	suppressed
Zafirlukast	Zafirlukast	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error